Status:

ENROLLING_BY_INVITATION

Assessing a New Tool to Assess Frailty in Frail Hospitalized Elderly

Lead Sponsor:

University of British Columbia

Conditions:

Frail Elderly Syndrome

Eligibility:

All Genders

65+ years

Brief Summary

The major purpose of this study is to establish the use of daily step counts as inexpensive, easy to measure marker for frailty and sarcopenia in an inpatient population of older adults.

Detailed Description

The total time involved to complete study procedures will be between 2-3 hours at your enrollment and up to 10 minutes at your discharge. Investigators will invite participants to enrol in this study ...

Eligibility Criteria

Inclusion

  • be 65 years of age or older
  • be admitted in ACE Unit

Exclusion

  • be less than 65 years of age
  • be nonambulatory
  • be diagnosed with end-stage organ failure (end-stage COPD, renal failure requiring dialysis, end-stage heart failure)

Key Trial Info

Start Date :

June 1 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2025

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT04366388

Start Date

June 1 2022

End Date

December 1 2025

Last Update

May 9 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Gerontology Research Lab, Dept. of Medicine, Vancouver Coastal Health Research Institute, VGH Research Pavilion, Room 186-828 West 10th Avenue

Vancouver, British Columbia, Canada, V5Z 1M9

Assessing a New Tool to Assess Frailty in Frail Hospitalized Elderly | DecenTrialz